Clinical Trial Update: Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer

View source ↗

Summary

A Samsung Medical Center trial investigates using tumor genome sequencing to guide molecular targeted therapy in refractory breast cancer and in young breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Breast Cancer | Status: UNKNOWN